Huntington's disease phenocopies are clinically and genetically heterogeneous

Movement Disorders

Volumn 23, Issue 5, 2008, Pages 716-720

  Wild, Edward J ^a   Mudanohwo, Ese E ^a   Sweeney, Mary G ^a   Schneider, Susanne A ^a   Beck, Jon ^a   Bhatia, Kailash P ^a   Rossor, Martin N ^a   Davis, Mary B ^a   Tabrizi, Sarah J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Familial prion disease; HDL1; HDL2; Huntington's disease (HD); Phenocopies; SCA17

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DNA MODIFICATION; EXTRAPYRAMIDAL SYNDROME; FEMALE; FRIEDREICH ATAXIA; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; HUNTINGTON DISEASE LIKE SYNDROME 1; HUNTINGTON DISEASE LIKE SYNDROME 2; HUNTINGTON DISEASE LIKE SYNDROME 4; MALE; PHENOTYPE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; HUNTINGTON CHOREA; MIDDLE AGED; MOTOR DYSFUNCTION; PRION; PRION DISEASE; SYNDROME;

JUNCTOPHILIN; MEMBRANE PROTEIN; PRNP PROTEIN, HUMAN; TATA BINDING PROTEIN; TBP PROTEIN, HUMAN;

ADULT; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRIEDREICH ATAXIA; HUMANS; HUNTINGTON DISEASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOVEMENT DISORDERS; MUTAGENESIS, INSERTIONAL; PHENOTYPE; PRION DISEASES; PRIONS; SYNDROME; TATA-BOX BINDING PROTEIN;

EID: 44449161332     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21915     Document Type: Article

References (30)

1. Bates G, Harper PS, Jones L, editors. Huntington's disease, 3rd ed. Oxford: Oxford University Press; 2002. 558 p.
2. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
3. Kremer B, Goldberg P, Andrew SE, et al. A worldwide study of the Huntington's Disease mutation: the sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994;330:1401-1406.
4. Andrew SE, Goldberg YP, Kremer B, et al. Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet 1994;54:852-863.
5. Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol 2007;20:681-687.
6. Moore RC, Xiang F, Monaghan J, et al. Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 2001;69: 1385-1388.
7. Holmes SE, O'Hearn E, Rosenblatt A, et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 2001;29:377-378.
8. Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994;6:9-13.
9. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
10. Hanna MG, Davis MB, Sweeney MG, et al. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Disord 1998;13:339-340.
11. Curtis ARJ, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-354.
12. Stevanin G, Fujigasaki H, Lebre A-S, et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 2003;126:1599-1603.
13. Costa MdC, Andreia T-C, Marco C, et al. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet 2006;51:645-651.
14. Keckarevic M, Savic D, Svetel M, Kostic V, Vukosavic S, Romac S. Yugoslav HD phenocopies analyzed on the presence of mutations in PrP, ferritin, and Jp-3 genes. Int J Neurosci 2005;115:299-301.
15. Margolis RL, Holmes SE, Rosenblatt A, et al. Huntington's disease-like 2 (HDL2) in North America and Japan. Ann Neurol 2004;56:670-674.
16. Danek A, Walker RH. Neuroacanthocytosis Curr Opin Neurol 2005;18:386-392.
17. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408.
18. Hartig MB, Hörtnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006;59: 248-256.
19. Malandrini A, Fabrizi GM, Palmeri S, et al. Choreo-acanthocytosis like phenotype without acanthocytes: clinicopathological case report. A contribution to the knowledge of the functional pathology of the caudate nucleus. Acta Neuropathol 1993;86:651-658.
20. Sorrentino G, De Renzo A, Miniello S, Nori O, Bonavita V. Late appearance of acanthocytes during the course of chorea-acanthocytosis. J Neurol Sci 1999;163:175-178.
21. Breedveld GJ, Percy AK, MacDonald ME, et al. Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 2002;59:579-584.
22. Kleiner-Fisman G, Rogaeva E, Halliday W, et al. Benign hereditary chorea: clinical, genetic, and pathological findings. Ann Neurol 2003;54:244-247.
23. Schneider SA, van de Warrenburg BPC, Hughes TD, et al. Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family. Neurology 2006;67:1701-1703.
24. Kao CC, Lieberman PM, Schmidt MC, Zhou Q, Pei R, Berk AJ. Cloning of a transcriptionally active human TATA binding factor. Science 1990;248:1646-1650.
25. Cha JH. Transcriptional dysregulation in Huntington's disease. Trends Neurosci 2000;23:387-392.
26. Rodda RA. Cerebellar atrophy in Huntington's disease. J Neurol Sci 1991;50:147-157.
27. Fennema-Notestine C, Archibald SL, Jacobson MW, et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 2004;63:989-995.
28. n tract in the Friedreich ataxia (STM7) gene. Hum Genet 1997;99:834-836.
29. Mead S, Poulter M, Beck J, et al. Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 2006;129(Part 9):2297-2317.
30. Maciel P, Cruz VT, Constante M, et al. Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology 2005;65:603-605.